Her primary areas of investigation include Molecular biology, Genetics, Chromosomal fragile site, Chromosome Fragile Site and Gene. Her biological study spans a wide range of topics, including Nucleic acid sequence, Gene family, Complementary DNA, Peptide sequence and Cell surface receptor. Trinucleotide repeat expansion, Fragile X syndrome, Chromosome, X chromosome and Cytogenetics are the core of her Genetics study.
Her research investigates the connection between Chromosomal fragile site and topics such as Restriction map that intersect with problems in Genotype and Molecular probe. In her research on the topic of Chromosome Fragile Site, Intron, Sequence analysis, Contig, Chromosomal translocation and Loss of heterozygosity is strongly related with Locus. Her work on Gene mapping and Exon as part of general Gene study is frequently connected to Mucopolysaccharidosis Type IIIA, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her primary areas of study are Genetics, Molecular biology, Gene, Gene mapping and Chromosomal fragile site. Her Genetics research focuses on Chromosome, Locus, Chromosome 16, Karyotype and X chromosome. In her research, Receptor is intimately related to Southern blot, which falls under the overarching field of Molecular biology.
Elizabeth Baker combines subjects such as Hybridization probe, Molecular probe, Restriction fragment length polymorphism, Fluorescence in situ hybridization and Chromosome 22 with her study of Gene mapping. Her research integrates issues of DNA, Chromosome Fragility, Fragile X syndrome and Breakpoint in her study of Chromosomal fragile site. Her studies in Chromosome Fragile Site integrate themes in fields like Jacobsen syndrome and Allele, Trinucleotide repeat expansion.
Elizabeth Baker spends much of her time researching Genetics, Molecular biology, Gene, Chromosome and Chromosomal fragile site. Her Karyotype, Subtelomere, Chromosomal translocation, X chromosome and Fluorescence in situ hybridization study are her primary interests in Genetics. Her research in Molecular biology intersects with topics in Complementary DNA, Transgene and Recombinant DNA.
Her Chromosome research focuses on Gene duplication and how it relates to Peptide sequence, Transmembrane protein and Northern blot. She is interested in Chromosome Fragile Site, which is a branch of Chromosomal fragile site. Her work carried out in the field of Chromosome Fragile Site brings together such families of science as Allele, Trinucleotide repeat expansion and Locus.
Genetics, Gene, Chromosomal fragile site, Exon and Chromosome Fragile Site are her primary areas of study. X chromosome, Karyotype and Cytogenetics are the subjects of her Genetics studies. Elizabeth Baker works in the field of Gene, namely Mutation.
Her Chromosome Fragile Site study integrates concerns from other disciplines, such as Allele, Loss of heterozygosity, Trinucleotide repeat expansion, Molecular biology and Locus. Her study in Trinucleotide repeat expansion is interdisciplinary in nature, drawing from both Chromosome Fragility, Contig, Chromosomal translocation and CpG site. Her Locus study incorporates themes from Nucleic acid sequence, Sequence analysis and Intron.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n.
EJ Kremer;M Pritchard;M Lynch;S Yu.
Fragile X genotype characterized by an unstable region of DNA
S. Yu;M. Pritchard;E. Kremer;M. Lynch.
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
Craig A. Smith;Hans Juergen Gruss;Terri Davis;Dirk Anderson.
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
P.R. Baum;R.B. Gayle rd;F. Ramsdell;S. Srinivasan.
The EMBO Journal (1994)
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor
Raymond G. Goodwin;Mark R. Alderson;Craig A. Smith;Richard J. Armitage.
Molecular and biological characterization of human 4-1BB and its ligand.
Mark R. Alderson;Craig A. Smith;Teresa W. Tough;Terri Davis-Smith.
European Journal of Immunology (1994)
bcl-w, a novel member of the bcl-2 family, promotes cell survival.
Leonie Gibson;Shaun P. Holmgreen;David C.S. Huang;Ora Bernard.
The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization.
C R Maliszewski;G J Delespesse;M A Schoenborn;R J Armitage.
Journal of Immunology (1994)
Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells
Karin Ried;Merran Finnis;Lynne Hobson;Marie Mangelsdorf.
Human Molecular Genetics (2000)
Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells
Alexander B. H. Bakker;Elizabeth Baker;Grant R. Sutherland;Joseph H. Phillips.
Proceedings of the National Academy of Sciences of the United States of America (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: